ProQR Therapeutics (PRQR) Net Income towards Common Stockholders Growth (5y) (2018 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | ProQR Therapeutics | 174.11 Mn | 66.54 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 10.62% |
| Sep 30, 2025 | 3.86% |
| Jun 30, 2025 | -25.49% |
| Mar 31, 2025 | 9.11% |
| Dec 31, 2024 | 13.67% |
| Sep 30, 2024 | 7.16% |
| Jun 30, 2024 | 26.03% |
| Mar 31, 2024 | 12.36% |
| Dec 31, 2023 | 18.50% |
| Sep 30, 2023 | 1.03% |
| Jun 30, 2023 | 0.13% |
| Mar 31, 2023 | -276.06% |
| Dec 31, 2022 | -24.75% |
| Sep 30, 2022 | -352.90% |
| Jun 30, 2022 | -3.19% |
| Mar 31, 2022 | -27.87% |
| Dec 31, 2021 | -16.96% |
| Sep 30, 2021 | -9.44% |
| Jun 30, 2021 | -11.20% |
| Mar 31, 2021 | -9.37% |
| Dec 31, 2020 | -18.97% |
| Sep 30, 2020 | -17.44% |
| Jun 30, 2020 | 13.27% |
| Mar 31, 2020 | 33.06% |
| Dec 31, 2019 | -51.79% |
| Sep 30, 2019 | -24.70% |
| Mar 31, 2019 | -44.62% |
| Dec 31, 2018 | -46.04% |
| Sep 30, 2018 | -42.96% |